Margins hit 27%, but Oct price hikes will prove the pudding
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade A
Maintained 90%+ utilization track record, margins beat prior ~20% guidance, 115,000-ton expansion on schedule
Cautiously Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong Q1 delivery (27% EBITDA margin, +23% PAT) validates pricing power, but October price hike absorption remains unproven amid competitive dynamics. Structural EAF demand thesis robust (71M ton capacity planned), yet near-term relies on competitors not flooding the market.
₹681 Cr
Revenue · +11% YoY₹122 Cr
Reported PAT · +23% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
Operated at 90% plus capacity utilization
METDelivered at 90%+ utilization, maintained operational efficiency
Margins expanded to 27% EBITDA vs 25% prior year
METConsolidated EBITDA margin 27% vs 25% prior year—supported
Realized 7-8% price improvement in Q1
METRevenue ₹681 Cr at 90%+ capacity: realization gain evident vs volumes
No volume loss in Q1 despite Middle East war
METDelivered 91% utilization, no stated volume decline; diversification absorbed
Pricing increases Oct onwards; competitor hikes $600–$1,200/ton
PartialBooked through Sept, new hikes timing confirmed; magnitude not yet locked
Earnings quality
What changed since the last call
EBITDA margin guidance upgraded
UpgradePrior: ~20% for two quarters; actual Q1 27% (and target 28-29% to maintain). Realization + mix beat expectations.
Price increase timing clarified
UpgradePrior vague on timing; now Oct onwards, with competitor marks ($600–$1,200/ton) in public domain; intent credible but absorption unknown
Capacity expansion timeline reaffirmed
Neutral115,000-ton expansion to early 2028 maintained; no acceleration or delay; EAF demand backdrop strengthened (OECD 71M tons)
Needle coke inflation quantified
DowngradeNew disclosure: $200–$300/ton increase since Middle East disruptions; 10-15% total cost inflation; will flow through Nov–Jan
The Q&A
Q&A pressed hard on pricing specifics (dollar/ton, % of volume booked at new levels), US tariff risk, and competitor price stickiness. Management deflected on competitive disclosures but held firm on margin maintenance conviction and 90%+ utilization commitment. No concessions on near-term softness.
Revenue mix, war impact — Amit Lahoti, Aditya Birla
PartialMENA ~20% over time, no volume loss this quarter, diversified to 30+ countries, minimal shipping disruption
Pricing trajectory, cost coverage — Ahmed Unifi Capital
PartialCompetitors announced $600–$1,200/ton hikes, we'll follow, booked through Sept/Oct, price inflation unbooked until Nov-Jan, won't disclose specifics
EAF capacity timing and track record — Akhilesh Kumar, Emkay Global
Answered8–10M tons H1 done, 60M tons '26–'28, 70% TACC contracts closing Sept, ₹1,500 Cr gross debt planned
Needle coke cost lag and pricing magnitude — Rohan, Arihant Capital
PartialEnd of year impact (45-day shipping + 45-day process cycle), can't disclose dollars, new bookings at higher prices
Margin sustainability and Greentech revenue — Deepak Poddar, Sapphire Capital
PartialWill maintain 28-29% margins, anode FY29 full run ₹1,500+ Cr (40-50% util FY28 = ₹600-700 Cr), hydro free cash ₹320-350 Cr/year, 4-digit EBITDA by 2030
US tariff exposure and diversion — Ronak Agarwal, iThought PMS
AnsweredUS only ~10% (not 20%), well-diversified, can easily absorb elsewhere, competitors all over world, won't leave US
Pricing and market dynamics — Kirtan Mehta, Baroda BNP
Answered$200–$300 needle coke rise, realization improvement primary driver + old stock benefit, US <10%, CVD July, dumping Sept
Guidance
No formal FY27 target; implicitly tracking volume utilization 90-95%
HighCompany track record strong; maintained 90%+ for years; structural EAF demand supports sustained run rates
Target maintain 28-29% EBITDA margin (per MD at call end)
MediumQ1 was 27% with benefit of old low-cost coke stock; forward high-cost input entry (~Nov) needs pricing offset to hit 28-29%
115,000-ton expansion capex on track for early 2028 commissioning
HighPrior expansion to 100,000 tons hit; EAF roadmap validates demand case; no specific capex spend phasing disclosed
TACC anode ₹2,200-₹2,300 Cr capex; 40% spent, balance over 3 quarters; 90-95% complete by FY27 end
MediumAnode capex phasing clear, 4-5 year payback assumed, 70% of 20K-ton capacity pre-sold by Sept
Risks the call surfaced
Pricing power execution
HighManagement guides Oct price hike but won't quantify; competitors (GrafTech $600-1200, Tokai $930/ton) already announced; steelmaker absorption TBD
Input cost inflation lag
MediumNeedle coke +$200–$300/ton since ME disruptions; Q1 benefited from 3-4 month old stock buffer; Nov-Jan ₹50-100 Cr+ impact if unhedged
US tariff and trade risk
LowUS ~10% of revenue; CVD due late July, dumping AD due Sept; HEG denies dumping; competitors also exposed; volume rerouting plan exists
Global EAF capacity commissioning risk
MediumOECD roadmap cited, but 25-30M tons already done in '24-'25; 60M tons '26-'28 is dependent on capital project execution; 10-15% variance plausible
Demerger execution and Greentech debt
LowDemerger progressing; NCLT order awaited; TACC anode capex ₹2,200 Cr, SBI debt ₹1,240 Cr, balance from equity/accruals; HEG parent remains debt-free
Management
Score 7/10. Chairman articulate on macro trends and structural demand thesis; deflects competitive details appropriately (NDA-bound). CFO clear on financials; ESG and execution roadmap credible. Some evasion on pricing specifics to avoid forward guidance trap. HEG hit 100K-ton target; maintained 90%+ utilization consistently over years; Q1 margin 27% beats prior ~20% guidance; TACC 70% contracts closed by Sept indicates disciplined project execution.
1 · Late Jul 2026
US CVD/ADD preliminary ruling (10% exposure); diversion to other markets assumed
2 · Sep 2026
US AD final ruling; competitor price hike absorption data point emerges
3 · Oct 2026
HEG price increases take effect; margin sustainability tested across geographies
Structural EAF demand thesis robust (71M ton capacity planned), yet near-term relies on competitors not flooding the market.
Informational and educational content only. Not investment advice.